Table 3.

HRs for colorectal cancer mortality stratified by baseline variables

HRs (95% CI) comparing those with CRP levels >0.3 mg/dL to those with levels ≤0.3 mg/dL
Age adjustedMultivariable adjusteda
All participants2.85 (1.67–4.88)3.29 (1.87–5.79)
Gender
 Male3.09 (1.54–6.18)3.28 (1.56–6.89)
 Female2.79 (1.05–7.44)3.38 (1.00–11.42)
Race–ethnicity
 Non-Hispanic white4.06 (2.11–7.83)5.01 (2.40–10.44)
 Non-Hispanic black0.72 (0.32–1.61)1.09 (0.51–2.37)
 Mexican-American2.67 (0.74–9.67)3.26 (0.71–14.83)
BMI
 <25 kg/m25.76 (2.32–14.31)5.99 (2.20–16.27)
 25–29.9 kg/m21.37 (0.64–2.95)1.28 (0.49–3.37)
 ≥30 kg/m22.24 (0.75–6.68)3.13 (1.11–8.80)
Smoking status
 Current smoker5.86 (1.73–19.52)5.28 (1.21–22.93)
 Former smoker3.11 (1.29–7.51)4.35 (2.01–9.40)
 Never smoker1.92 (1.06–3.46)2.16 (0.77–6.06)
Alcohol consumption
 Yes3.24 (1.40–7.48)5.31 (1.75–16.15)
 No2.57 (1.25–5.30)2.54 (1.16–5.53)
Physical activityb
 More active1.71 (0.70–4.16)1.26 (0.47–3.40)
 Less active8.34 (1.37–50.70)6.89 (2.12–22.36)
 About the same4.04 (1.89–8.61)5.10 (2.20–11.85)
Hypertension status
 Yes2.17 (1.21–3.90)2.91 (1.49–5.68)
 No3.69 (1.56–8.71)3.51 (1.20–10.23)
Diabetes mellitus status
 Yes1.23 (0.32–4.72)1.36 (0.25–7.37)
 No3.25 (1.66–6.33)3.29 (1.89–5.70)
Hypercholesterolemia
 Yes2.95 (1.01–8.61)2.45 (0.88–6.80)
 No2.85 (1.54–5.25)3.78 (1.93–7.38)
Supplement use
 Yes3.02 (1.16–7.80)5.15 (1.62–16.34)
 No2.69 (1.27–5.69)2.49 (1.13–5.47)
  • aAdjusted for age, gender, race–ethnicity, level of education, annual family income, BMI, pack-years of smoking, serum cotinine levels, alcohol consumption, physical activity, hypertension status, diabetes status, hypercholesterolemia, supplement use, nonsteroidal anti-inflammatory drug use, and hormone use in women.

  • bCompared with others of same age.